First Time Loading...

Cochlear Ltd
ASX:COH

Watchlist Manager
Cochlear Ltd Logo
Cochlear Ltd
ASX:COH
Watchlist
Price: 320.82 AUD 1.43% Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one COH stock under the Base Case scenario is 277.85 AUD. Compared to the current market price of 320.82 AUD, Cochlear Ltd is Overvalued by 13%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

COH Relative Value
Base Case
277.85 AUD
Overvaluation 13%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

9.8
P/S
P/S
Price to Sales
9.8
vs History
22
vs Industry
14
Median 3Y
9.2
Median 5Y
9.1
Industry
2.4
Forward
9.2
More Details
59.9
P/E
P/E
Price to Earnings
59.9
vs History
11
vs Industry
7
Median 3Y
53.1
Median 5Y
45.3
Industry
23.4
Forward
53.5
More Details
48.8
P/OCF
P/OCF
Price to OCF
48.8
vs History
23
vs Industry
7
Median 3Y
46.2
Median 5Y
42
Industry
15.5
More Details
78.8
P/FCFE
P/FCFE
Price to FCFE
78.8
vs History
22
vs Industry
7
Median 3Y
69.1
Median 5Y
56.8
Industry
23.2
More Details
11.8
P/B
P/B
Price to Book Value
11.8
vs History
28
vs Industry
5
Median 3Y
8.7
Median 5Y
9.1
Industry
2.3
More Details
9.6
EV/S
EV/S
Enterprise Value to Sales
9.6
vs History
20
vs Industry
13
Median 3Y
8.9
Median 5Y
8.9
Industry
2.5
Forward
9.1
More Details
12.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
12.7
vs History
22
vs Industry
17
Median 3Y
12
Median 5Y
11.8
Industry
5.3
More Details
42.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
42.1
vs History
34
vs Industry
6
Median 3Y
38.9
Median 5Y
38
Industry
12.6
Forward
33.7
More Details
42.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
42.1
vs History
34
vs Industry
9
Median 3Y
38.9
Median 5Y
38
Industry
17.2
Forward
39.2
More Details
48
EV/OCF
EV/OCF
Enterprise Value to OCF
48
vs History
22
vs Industry
7
Median 3Y
45.1
Median 5Y
41.9
Industry
15.3
More Details
61.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
61.8
vs History
44
vs Industry
8
Median 3Y
58.9
Median 5Y
58.9
Industry
19.8
More Details
11.5
EV/IC
EV/IC
Enterprise Value to IC
11.5
vs History
6
vs Industry
7
Median 3Y
8.7
Median 5Y
8.7
Industry
2
More Details

Multiples Across Competitors

COH Competitors Multiples
Cochlear Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Cochlear Ltd
ASX:COH
21B AUD 9.8 59.9 42.1 42.1
US
Abbott Laboratories
NYSE:ABT
183.6B USD 4.6 32.6 19.2 28.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
135.3B USD 18.5 68.1 55.8 70
US
Stryker Corp
NYSE:SYK
125.1B USD 6 37.2 24.2 29.7
IE
Medtronic PLC
NYSE:MDT
108.6B USD 3.4 25.9 13.8 19.5
US
Boston Scientific Corp
NYSE:BSX
106.8B USD 7.3 60.5 30.8 45.5
US
Becton Dickinson and Co
NYSE:BDX
67.8B USD 3.5 55.6 18.6 39.4
DE
Siemens Healthineers AG
XETRA:SHL
57.9B EUR 2.7 38.1 18.3 30.9
US
Edwards Lifesciences Corp
NYSE:EW
51.3B USD 8.4 36.3 26.4 28.5
US
Dexcom Inc
NASDAQ:DXCM
50.8B USD 13.4 79.5 59.5 77.4
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368.4B CNY 10.7 32.5 28.3 28.3

See Also

Summary
COH intrinsic value, competitors valuation, and company profile.
DCF Valuation
COH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
COH stock valuation using valuation multiples.
Wall Street Estimates
COH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
COH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.